Regenxbio (RGNX) Shareholder's Equity (2014 - 2025)
Regenxbio (RGNX) Shareholder's Equity (2014 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
14.38 Mn |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
502.95 Mn |
| 10 |
Regenxbio |
315.11 Mn |
85.04 Mn |
- |
102.73 Mn |
| Date | Value |
|---|
| Dec 31, 2025 |
102.73 Mn |
| Sep 30, 2025 |
161.45 Mn |
| Jun 30, 2025 |
213.68 Mn |
| Mar 31, 2025 |
274.20 Mn |
| Dec 31, 2024 |
259.65 Mn |
| Sep 30, 2024 |
301.42 Mn |
| Jun 30, 2024 |
348.27 Mn |
| Mar 31, 2024 |
390.67 Mn |
| Dec 31, 2023 |
311.74 Mn |
| Sep 30, 2023 |
363.10 Mn |
| Jun 30, 2023 |
405.86 Mn |
| Mar 31, 2023 |
465.14 Mn |
| Dec 31, 2022 |
516.20 Mn |
| Sep 30, 2022 |
563.82 Mn |
| Jun 30, 2022 |
630.52 Mn |
| Mar 31, 2022 |
689.67 Mn |
| Dec 31, 2021 |
764.30 Mn |
| Sep 30, 2021 |
461.41 Mn |
| Jun 30, 2021 |
507.25 Mn |
| Mar 31, 2021 |
554.50 Mn |
